Study of ΔF508 mutation by genetic panel method in Azerbaijan population

Article Sidebar

PDF
Number of views 101

Published: Feb 16, 2024
Issue
No. 188 (2024): 15th ISPC «Scientific Research in XXI Century» (February 16-18, 2024; Ottawa, Canada).
Section
Biology and Biotechnology
Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Main Article Content

A. Salimova
Azerbaijan Medical University, Department of Medical Biology and Genetics; Republic of Azerbaijan
N. Mammadova
Azerbaijan Medical University, Department of Medical Biology and Genetics; Republic of Azerbaijan
L. Huseynova
Azerbaijan Medical University, Department of Medical Biology and Genetics; Republic of Azerbaijan

Google Scholar


Article Details

How to Cite
Salimova, A., Mammadova, N., & Huseynova, L. (2024). Study of ΔF508 mutation by genetic panel method in Azerbaijan population. Scientific Collection «InterConf», (188), 200–203. Retrieved from https://archive.interconf.center/index.php/conference-proceeding/article/view/5404

References

Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, Benos DJ, Quick MW, Kirk KL (November 1997). "Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms". Nature. 390 (6657): 302–5.

Cheng, J., Cebotaru, V., Cebotaru, L., Guggino, W. B. Syntaxin 6 and CAL mediate the degradation of the cystic fibrosis transmembrane conductance regulator. Molec. Biol. Cell 21: 1178-1187, 2010.

Welsh M.J. and Smith A. (1999) Molecular Mechanism of CFTR chlorite channel dysfunction in Cystic Fibrosis. Cell.. Vol.73. 1251-1254.

De Boeck, Kris; Amaral, Margarida D (August 2016). "Progress in therapies for cystic fibrosis". The Lancet Respiratory Medicine. 4 (8): 662–674.

Thiagarajah JR, Verkman AS (September 2012). "CFTR inhibitors for treating diarrheal disease". Clinical Pharmacology and Therapeutics. 92 (3): 287–90.

Guimbellot, Jennifer; Sharma, Jyoti; Rowe, Steven M. (November 2017). "Toward inclusive therapy with CFTR modulators: Progress and challenges". Pediatric Pulmonology. 52(S48): p.4–14.

Egan ME (March 2016). "Genetics of Cystic Fibrosis: Clinical Implications". Clinics in Chest Medicine. 37 (1): 9–16.

Huseynova L.S., Nasibova Z.S. Molecular-Genetic Research of Early Epileptic Encephalopathy and Cystic Fibrosis Disease in Population of Azerbaijan. Khazar Journal of Science and Technology (KJSAT). Khazar University, Azerbaijan. Vol. 4, № 1, 2020.p. 33-41.

Aghayeva S.A., Huseynova L.S., Hagverdiyeva R.R. Combined mutation of DMD and CFTR genes in an Azerbaijani family. İnternational Journal of Life Science and Pharma Research. İSSN 2250-0480. İndia. 2021: doi 10.22376/ijpbs/lpr. Volume 11. No4 (July) 2021.P. 35-41.

Huseynova L.S., Aliyeva K.A., Najafzada G.B., Yusufova Kh.J., Hashimova A.R. Molecular genetic research of MEFV gene in population of Azerbaijan Republic. Sylwan. Poland. 162 (5)., 2018. p.31-36.

Huseynova L.S., Aliyeva K.A., Rasulov E.M., Valiyeva G.A. Molecular genetic characteristics of MEFV gene for the Familial Mediterranean Fever disease in patient from Azerbaijan Republic. Human genome and health 2 nd International Conference.Translational Medicine in the Era of Omics. 2019. p.13.